• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013-2021 年,德国一大学附属医院产碳青霉烯酶分离株获得性毒力因子的高频率。

High frequency of acquired virulence factors in carbapenemase-producing isolates from a large German university hospital, 2013-2021.

机构信息

Institute for Medical Microbiology, Immunology and Hygiene, University Hospital Cologne and Faculty of Medicine, University of Cologne, Cologne, Germany.

Institute of Medical Microbiology and Virology, University of Oldenburg, Oldenburg, Germany.

出版信息

Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0060224. doi: 10.1128/aac.00602-24. Epub 2024 Oct 4.

DOI:10.1128/aac.00602-24
PMID:39365038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11539210/
Abstract

Carbapenemase-producing (CP-Kp) isolates are a public health concern as they can cause severe hospital-acquired infections that are difficult to treat. It has recently been shown that CP-Kp can take up virulence factors from hypervirulent lineages. In this study, 109 clinical CP-Kp isolates from the University Hospital Cologne were examined for the presence of acquired virulence factors using whole-genome sequencing and phenotypic tests, and results were linked to clinical data. The virulence factor was present in 18/109 of the CP-Kp isolates. Other acquired virulence factors, such as , , , , , and hypervirulence-associated capsule types were detected in various combinations among these isolates. The -positive isolates produced OXA-232 ( = 7), OXA-48 ( = 6), OXA-48+NDM ( = 3), NDM, and KPC (each = 1), and 7/18 isolates were resistant to ceftazidime-avibactam, colistin, and/or cefiderocol. Four isolates carried hybrid plasmids that harbored acquired virulence factors alongside the carbapenemase genes or . In 15/18 patients, -positive CP-Kp were isolated from a clinically manifest infection site. Among these, four patients had osteomyelitis, and four patients died from pneumonia with OXA-232-producing ST231 isolates, three of them as part of an outbreak. In conclusion, acquired virulence factors are frequently detected in various combinations in carbapenemase-producing isolates in Germany, warranting continuous monitoring of infections caused by these strains.

摘要

产碳青霉烯酶的 (CP-Kp) 分离株是一个公共卫生关注点,因为它们可导致严重的医院获得性感染,且难以治疗。最近已经表明,CP-Kp 可以从高毒力谱系中获取毒力因子。在这项研究中,通过全基因组测序和表型试验,检测了科隆大学医院的 109 株临床 CP-Kp 分离株中获得的毒力因子的存在情况,并将结果与临床数据相关联。18/109 株 CP-Kp 分离株中存在毒力因子。在这些分离株中,还检测到其他获得的毒力因子,如 、 、 、 、 和与高毒力相关的荚膜型,以各种组合存在。-阳性分离株产生 OXA-232(=7)、OXA-48(=6)、OXA-48+NDM(=3)、NDM 和 KPC(各=1),7/18 株对头孢他啶-阿维巴坦、黏菌素和/或头孢地尔科耐药。4 株分离株携带杂合质粒,这些质粒除了携带碳青霉烯酶基因 或 外,还携带获得的毒力因子。在 18 例患者中,从临床表现感染部位分离出-阳性 CP-Kp。在这些患者中,有 4 例患有骨髓炎,有 4 例因肺炎死亡,携带 OXA-232 的 ST231 分离株,其中 3 例是疫情的一部分。总之,在德国产碳青霉烯酶的 分离株中经常以各种组合检测到获得的毒力因子,需要对这些菌株引起的感染进行持续监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/0d1f20896bca/aac.00602-24.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/7f638a571363/aac.00602-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/f3ebec88fcaa/aac.00602-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/0d1f20896bca/aac.00602-24.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/7f638a571363/aac.00602-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/f3ebec88fcaa/aac.00602-24.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/365e/11539210/0d1f20896bca/aac.00602-24.f003.jpg

相似文献

1
High frequency of acquired virulence factors in carbapenemase-producing isolates from a large German university hospital, 2013-2021.2013-2021 年,德国一大学附属医院产碳青霉烯酶分离株获得性毒力因子的高频率。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0060224. doi: 10.1128/aac.00602-24. Epub 2024 Oct 4.
2
evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by sequence type 512.由 512 型序列引起的肝脓肿中向高黏液性和头孢他啶/阿维巴坦耐药性的进化。
mSphere. 2024 Sep 25;9(9):e0042324. doi: 10.1128/msphere.00423-24. Epub 2024 Aug 22.
3
Carbapenem-resistant infections in Chinese children: activities of ceftazidime-avibactam and aztreonam-avibactam against carbapenemase-producing strains in a two-center study.中国儿童碳青霉烯类耐药感染:头孢他啶-阿维巴坦和氨曲南-阿维巴坦对产碳青霉烯酶菌株活性的双中心研究
Front Cell Infect Microbiol. 2025 Mar 26;15:1545999. doi: 10.3389/fcimb.2025.1545999. eCollection 2025.
4
Characterization of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae.一种新型KPC-2变体KPC-228的特性分析,该变体使一株ST11-KL64高毒力肺炎克雷伯菌对头孢他啶-阿维巴坦产生耐药性。
Int J Antimicrob Agents. 2025 Mar;65(3):107411. doi: 10.1016/j.ijantimicag.2024.107411. Epub 2024 Dec 19.
5
Characterization of OXA232-Producing Carbapenem-Resistant : Genomic Analysis and Virulence Assessment.产OXA232碳青霉烯耐药菌的特征:基因组分析与毒力评估
Pol J Microbiol. 2025 Mar 26;74(1):82-94. doi: 10.33073/pjm-2025-007. eCollection 2025 Mar 1.
6
Genomic dynamics of high-risk carbapenem-resistant klebsiella pneumoniae clones carrying hypervirulence determinants in Egyptian clinical settings.埃及临床环境中携带超毒力决定因子的高风险碳青霉烯类耐药肺炎克雷伯菌克隆的基因组动态。
BMC Infect Dis. 2024 Oct 22;24(1):1193. doi: 10.1186/s12879-024-10056-1.
7
Analysis of the virulence of a lethal, carbapenem-resistant hypervirulent KPC-33-producing Klebsiella pneumoniae: Emergence of ST11-KL64 hv-CRKP in ICU.一株产碳青霉烯酶的致死性高毒力肺炎克雷伯菌KPC-33的毒力分析:ICU中ST11-KL64高毒力碳青霉烯耐药肺炎克雷伯菌的出现
Microb Pathog. 2025 Jan;198:107154. doi: 10.1016/j.micpath.2024.107154. Epub 2024 Nov 23.
8
Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.在引入头孢他啶/阿维巴坦后,希腊 ICU 中产生碳青霉烯酶的肺炎克雷伯菌的流行情况从 blaKPC 到 blaVIM 携带株的逆转。
J Antimicrob Chemother. 2019 Jul 1;74(7):2051-2054. doi: 10.1093/jac/dkz125.
9
Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years.三年间意大利北部三家大学医院流行的产碳青霉烯酶肺炎克雷伯菌(KPC-Kp)菌株的基因组特征。
Antimicrob Resist Infect Control. 2024 Jul 3;13(1):70. doi: 10.1186/s13756-024-01429-x.
10
Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a -Carrying Virulent Plasmid and a -Carrying Plasmid in an Egyptian Hospital.埃及医院中携带 - 碳青霉烯酶基因的高毒力耐碳青霉烯肺炎克雷伯菌的流行:携带毒力质粒和 - 碳青霉烯酶基因的质粒共同存在
mSphere. 2021 May 19;6(3):e00088-21. doi: 10.1128/mSphere.00088-21.

引用本文的文献

1
Clinical Characterization, Risk Factors, and Mortality in Patients with Carbapenem-Resistant Hypervirulent Intra-Abdominal Infections.耐碳青霉烯类高毒力腹腔内感染患者的临床特征、危险因素及死亡率
Infect Drug Resist. 2025 Jul 23;18:3647-3660. doi: 10.2147/IDR.S529532. eCollection 2025.
2
Cross-border spread of a mosaic resistance (OXA-48) and virulence (aerobactin) plasmid in : a European Antimicrobial Resistance Genes Surveillance Network investigation, Europe, February 2019 to October 2024.一种镶嵌抗性(OXA-48)和毒力(气杆菌素)质粒在欧洲的跨境传播:欧洲抗菌药物耐药基因监测网络调查,欧洲,2019年2月至2024年10月
Euro Surveill. 2025 Jul;30(27). doi: 10.2807/1560-7917.ES.2025.30.27.2500439.
3

本文引用的文献

1
Differentiation of hypervirulent and classical with acquired drug resistance.区分高毒力和经典型以及获得性耐药性。
mBio. 2024 Feb 14;15(2):e0286723. doi: 10.1128/mbio.02867-23. Epub 2024 Jan 17.
2
Proteus mirabilis - analysis of a concealed source of carbapenemases and development of a diagnostic algorithm for detection.奇异变形杆菌——碳青霉烯酶隐匿来源分析与检测诊断算法的建立
Clin Microbiol Infect. 2023 Sep;29(9):1198.e1-1198.e6. doi: 10.1016/j.cmi.2023.05.032. Epub 2023 Jun 2.
3
Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland.
A systematic review of hypervirulent research: bibliometric and topic modeling perspectives.
高毒力研究的系统综述:文献计量学与主题建模视角
Front Med (Lausanne). 2025 Apr 11;12:1545678. doi: 10.3389/fmed.2025.1545678. eCollection 2025.
4
Hypervirulent (hv): Overview, Epidemiology, and Laboratory Detection.高毒力(hv):概述、流行病学及实验室检测
Pathog Immun. 2025 Jan 24;10(1):80-119. doi: 10.20411/pai.v10i1.777. eCollection 2024.
瑞士出现产碳青霉烯酶高毒力肺炎克雷伯菌。
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0142422. doi: 10.1128/aac.01424-22. Epub 2023 Feb 28.
4
Molecular surveillance of multidrug-resistant Gram-negative bacteria in Ukrainian patients, Germany, March to June 2022.2022 年 3 月至 6 月德国对乌克兰患者中耐多药革兰氏阴性菌的分子监测。
Euro Surveill. 2023 Jan;28(1). doi: 10.2807/1560-7917.ES.2023.28.1.2200850.
5
Nosocomial outbreak by NDM-1-producing highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022.2021 年 8 月至 2022 年 6 月,意大利佛罗伦萨发生产 NDM-1 的耐碳青霉烯头孢地尔 洛高度耐药的医院感染爆发。
Euro Surveill. 2022 Oct;27(43). doi: 10.2807/1560-7917.ES.2022.27.43.2200795.
6
Global spread and evolutionary convergence of multidrug-resistant and hypervirulent high-risk clones.全球传播和多重耐药性及高毒力高危克隆的进化趋同。
Pathog Glob Health. 2023 Jun;117(4):328-341. doi: 10.1080/20477724.2022.2121362. Epub 2022 Sep 11.
7
Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation.意大利托斯卡纳地区一起暴发的与产NDM-1的肺炎克雷伯菌ST147亚系相关的耐药基因组和毒力基因组累积:基因型和表型特征分析
Lancet Microbe. 2022 Mar;3(3):e224-e234. doi: 10.1016/S2666-5247(21)00268-8. Epub 2022 Feb 4.
8
Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam.对头孢他啶-阿维巴坦、亚胺培南-瑞来巴坦、美罗培南-维巴坦和头孢吡肟-他唑巴坦耐药的肺炎克雷伯菌突变株。
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0217921. doi: 10.1128/aac.02179-21. Epub 2022 Mar 16.
9
A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex.肺炎克雷伯菌及其相关种复合体的基因组监测框架和基因分型工具。
Nat Commun. 2021 Jul 7;12(1):4188. doi: 10.1038/s41467-021-24448-3.
10
Emergence of Hybrid Resistance and Virulence Plasmids Harboring New Delhi Metallo-β-Lactamase in in Russia.俄罗斯出现携带新德里金属β-内酰胺酶的混合耐药性和毒力质粒。
Antibiotics (Basel). 2021 Jun 9;10(6):691. doi: 10.3390/antibiotics10060691.